CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Overview Fund Activity
Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

31 hedge funds and large institutions have $2.29M invested in COSCIENS Biopharma Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+11
Holders Change %
+55%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
6
Reduced
5
Closed
5
Calls
$2.17M
Puts
$725K
Net Calls
+$1.44M
Net Calls Change
+$1.37M

Top Buyers

1
SM
1
Sabby Management
Florida
$682K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$389K
3
Millennium Management
3
Millennium Management
New York
$244K
4
VF
4
Virtu Financial
New York
$182K
5
EDRH
5
Edmond de Rothschild Holding
Switzerland
$114K

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$47K
2
Two Sigma Advisers
2
Two Sigma Advisers
New York
$0
3
UBS Group
3
UBS Group
Switzerland
$8K
4
Toronto Dominion Bank
4
Toronto Dominion Bank
Ontario, Canada
$15K
5
SFP
5
Sandbox Financial Partners
Maryland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TC
26
Truvestments Capital
Florida
$3K +$724 +7 +32%
FWM
27
Focused Wealth Management
New York
$1K -$1K -10 -50%
RIM
28
Rockbridge Investment Management
New York
$1K – – –
Citigroup
29
Citigroup
New York
$1K – – –
SPIA
30
Steward Partners Investment Advisory
New York
$8 – – –
Two Sigma Advisers
31
Two Sigma Advisers
New York
– -$79K -1,855 Closed
SFP
32
Sandbox Financial Partners
Maryland
– -$8K -195 Closed
RFA
33
Reilly Financial Advisors
California
– -$6K -130 Closed
DWM
34
Dorchester Wealth Management
Quebec, Canada
– -$4K -100 Closed
1
2